Sulfadimidine
ANTIINFECTIVES FOR SYSTEMIC USE
Also known as: sodium sulfamethazine, sulfadimerazine, sulfadimethyldiazine, sulfamethazine, sulfamethazine bisulfate, sulfamethazine sodium, sulfamethazine sodium salt
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sulfadimidine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1949. DrugCentral lists 2 molecular targets, including folP and GLO1.
- Approval status: ofm (first approved 1949 by the FDA).
- Molecular targets: folP and GLO1 (2 listed in DrugCentral).
- ATC code: J01EB03 (Short-acting sulfonamides).
- Molecular formula: C12H14N4O2S; molecular weight 278.33 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (8)
- Anemia due to enzyme deficiency
- Breastfeeding (mother)
- Disease of blood AND/OR blood-forming organ
- Disease of liver
- Kidney disease
- Megaloblastic anemia due to folate deficiency
- Porphyria
- Third trimester pregnancy
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Dihydropteroate synthase | folP | inhibitor | — |
| Lactoylglutathione lyase | GLO1 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1949-08-16 | FDA | — | LEDERLE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
J01EB03 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Short-acting sulfonamides |
J01EE05 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Combinations of sulfonamides and trimethoprim, incl. derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sulfadimidine is on its molecule page.
| Molecular formula | C12H14N4O2S |
|---|---|
| Molecular weight | 278.33 g/mol |
| CAS number | 57-68-1 |
| InChIKey | ASWVTGNCAZCNNR-UHFFFAOYSA-N |
| PubChem CID | 5327 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Sulfadimidine work?
Its molecular targets in DrugCentral include folP (inhibitor) and GLO1.
When was Sulfadimidine first approved?
Sulfadimidine was first approved by the FDA in 1949.
What is the chemical formula of Sulfadimidine?
Sulfadimidine has the molecular formula C12H14N4O2S and a molecular weight of 278.33 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2502 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL446 — compound record and bioactivity
- PubChem CID 5327 — chemical identifiers
- DrugBank DB01582 — drug record
- FDA UNII 48U51W007F — substance identity
- DailyMed: FDA labels for Sulfadimidine — current prescribing information (label search)
- UniProt Q04760 (GLO1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.